Cargando…
Gene and Cell Therapy for Muscular Dystrophies: Are We Getting There?
In the last few years, significant advances have occurred in the preclinical and clinical work toward gene and cell therapy for muscular dystrophy. At the time of this writing, several trials are ongoing and more are expected to start. It is thus a time of expectation, even though many hurdles remai...
Autores principales: | Galli, Francesco, Bragg, Laricia, Meggiolaro, Linda, Rossi, Maira, Caffarini, Miriam, Naz, Naila, Santoleri, Sabrina, Cossu, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211823/ https://www.ncbi.nlm.nih.gov/pubmed/30132372 http://dx.doi.org/10.1089/hum.2018.151 |
Ejemplares similares
-
MCAM contributes to the establishment of cell autonomous polarity in myogenic and chondrogenic differentiation
por: Moreno-Fortuny, Artal, et al.
Publicado: (2017) -
Targeting Nfix to fix muscular dystrophies
por: Rossi, Giuliana, et al.
Publicado: (2017) -
Cognitive profile of patients with facioscapulohumeral muscular dystrophy
por: dos Santos, Vanessa Brzoskowski, et al.
Publicado: (2021) -
Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020) -
Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy
por: Godi, Claudia, et al.
Publicado: (2016)